BioLineRx
BLRX

BioLineRx (BLRX) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$26.00Jun 17, 2025
Jones TradingUpgradedHold → Buy$12.00May 30, 2025
HC Wainwright & Co.MaintainedBuy$26.00May 28, 2025
Jones TradingDowngradedBuy → HoldApr 2, 2025
HC Wainwright & Co.MaintainedBuy$26.00 from $9.00Mar 31, 2025
HC Wainwright & Co.MaintainedBuy$9.00 from $21.00Nov 25, 2024
HC Wainwright & Co.MaintainedBuy$21.00Nov 6, 2024
Jones TradingInitiated CoverageBuy$2.00Sep 4, 2024
HC Wainwright & Co.MaintainedBuy$21.00Jun 3, 2024
HC Wainwright & Co.MaintainedBuy$21.00May 29, 2024
HC Wainwright & Co.MaintainedBuy$21.00Apr 17, 2024
HC Wainwright & Co.MaintainedBuy$21.00Mar 26, 2024
HC Wainwright & Co.MaintainedBuy$21.00Feb 29, 2024
HC Wainwright & Co.MaintainedBuy$21.00Nov 20, 2023
HC Wainwright & Co.MaintainedBuy$21.00 from $19.00Sep 15, 2023
HC Wainwright & Co.MaintainedBuy$19.00Aug 31, 2023
OppenheimerMaintainedOutperform$4.00May 25, 2023

Frequently asked questions

  • What is the latest analyst rating on BLRX?

    On Jun 17, 2025, HC Wainwright & Co. maintained BioLineRx at Buy with a price target of $26.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.